Collaborating for What’s Now & What’s Next: 1859

02/17/2021

JPM_1859

Collaborating for What’s Now & What’s Next: 1859

Devon Cayer, CEO & Co-Founder of 1859, shares how 1859 has teamed up with JLABS @ San Diego to miniaturize the medicine delivery process.

Related video

Related videos

2021 Inclusive Leadership Week: #ChooseToChallenge - Day 3

Related article

Related articles

5 April 2021

Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL

5 April 2021

Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza

©Johnson & Johnson Innovation LLC 2021. All Rights Reserved. Your use of the information on this site is subject to the terms of our Legal Notice. Please see our Privacy Policy and Do Not Sell My Personal Information form. This site is published by Johnson & Johnson Innovation LLC which is solely responsible for its contents. This site is intended for global audiences. Capitalized product names are trademarks of the Johnson & Johnson Family of Companies or its affiliates.